Published Date: 17 Mar 2023
Iran: According to a study published in Diabetology and Metabolic Syndrome, triglycerides are elevated in normoglycemic patients.
Read Full NewsTake 5 minutes to catch up on NeurologyLive®'s highlights from the week ending December 5, 2025.
Following stiripentol’s market authorization in Japan in November 2012, a postmarketing surveillance study was conducted in all patients with Dravet syndrome who initiated treatment.
A study reveals EEG and MRI biomarkers in MOGAD patients with epilepsy, highlighting potential early indicators for refractory epilepsy and improved treatment outcomes.
Despite the availability of antiseizure medications approved for Dravet syndrome, a recent survey presented at AES 2025 showed that these therapies remain underutilized in patients.
Serum Albumin Levels Can Predict Increased Cancer Risk in Hemodialysis
1.
New drug combination shows particularly good results in patients with HPV-negative head and neck cancer
2.
Early palliative care billing up from 2010 to 2019 for advanced cancer
3.
GFR-TKIs taken orally in cancer patients who have artery dissection and aneurysms.
4.
Infections the Main Cause of Nonrelapse Mortality After CAR-T for Blood Cancers
5.
Small Renal Mass Surveillance Does Not Affect Nephron-Sparing Surgery.
1.
IGF2BP1 in Blood Disorders: Therapeutic Potential and Comprehensive Functional Insights
2.
Everything You Need To Know About Trichelemmal Cysts: Symptoms, Causes, Diagnosis And Treatment
3.
HCC in Melanoma: Role of HCC Codes and Moderate Whole Body Hyperthermia
4.
Unlocking the Secrets of Improved Ovarian Cancer Survival Rates
5.
Case Study: Advancing Preclinical Oncology Drug Development with Quantitative Systems Pharmacology
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Current Scenario of Blood Cancer- Genomic Testing & Advancement in Diagnosis and Treatment
2.
An Eagles View - Evidence-based Discussion on Iron Deficiency Anemia- Panel Discussion- Part II
3.
Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part III
4.
Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part IV
5.
Newer Immunotherapies for Myeloma- A Comprehensive Overview
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation